In this 3rd position paper of its 2023 Medical Series, Smart Pharma Consulting analyses strategic, tactical and organizational best practices of Medical Affairs departments.
News
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues:
French health authorities intent – cautiously – to facilitate the development of the biosimilars market by: This...